University of Wisconsin Health - UW Carbone Cancer Center
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
O'Regan, Ruth
NCT04886531: Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Recruiting
2
48
US
Neratinib, Nerlynx, Letrozole (L) or Anastrozole (A), Femara, Arimidex, Trastuzumab, Herceptin
Ruth O'Regan, Puma Biotechnology, Inc., University of Rochester
Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast Cancer
09/25
10/25
NCT03090165: Ribociclib and Bicalutamide in AR+ TNBC

Recruiting
1/2
37
US
ribociclib, LEE011, Bicalutamide
Kari Wisinski, Novartis, Big Ten Cancer Research Consortium, University of Wisconsin, Madison
Triple Negative Breast Cancer
09/25
09/25
NCT03393741: Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

Terminated
N/A
5
US
Taxane, paclitaxel, nab-paclitaxel, docetaxel, Vinorelbine, vinca alkaloid, Ixabepilone, epothilone, Eribulin, halichondrins, Chemotherapy
University of Wisconsin, Madison, National Cancer Institute (NCI)
Breast Cancer, Breast Neoplasms
02/24
02/24
NCT03303846: Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

Active, not recruiting
N/A
344
US
Magnetic Resonance Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MRI, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Biospecimen Collection, Laboratory Biomarker Analysis
City of Hope Medical Center, National Cancer Institute (NCI)
Healthy Subject
04/26
04/26

Download Options